Revelation Biosciences (REVB) Balance Sheet: Assets & Liabilities

Revelation Biosciences (REVB) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Revelation Biosciences reported total assets of $11.58M and total liabilities of $2.72M. Shareholders' equity was $8.86M, up 88.2% from $4.71M a year earlier. Total debt stood at $746.78K against $10.70M in cash and short-term investments, a net cash position of $9.95M. That puts debt-to-equity at 0.08, compared with 0.00 a year earlier.

Revelation Biosciences Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Revelation Biosciences, Inc. (REVB) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	10.70	6.50	11.99	5.25	1.27	0.01	0.00
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.53	0.00
Cash & Short-Term Investments	10.70	6.50	11.99	5.25	1.27	0.54	0.00
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.11	0.05	0.16	0.15	0.64	0.11	0.00
Total Current Assets	10.81	6.57	12.15	5.40	1.91	0.65	0.00
Non-Current Assets
Property, Plant & Equipment (Net)	0.74	0.06	0.07	0.09	0.13	0.00	0.00
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	73.51	0.00
Other Non-Current Assets	0.03	0.00	0.00	0.00	0.00	0.00	0.02
Total Non-Current Assets	0.77	0.06	0.07	0.09	0.13	73.51	0.02
Total Assets	11.58	6.62	12.21	5.50	2.04	74.16	0.02
Current Liabilities
Accounts Payable	0.58	0.78	1.36	0.55	0.60	0.00	0.00
Short-Term Debt	0.02	0.00	0.00	0.00	0.02	0.00	0.00
Accrued Liabilities	1.40	1.13	1.15	0.99	1.53	0.34	-
Other Current Liabilities	1.40	0.00	4.20	3.90	1.53	3.43	0.03
Total Current Liabilities	2.00	1.91	5.56	4.45	2.14	3.43	0.03
Non-Current Liabilities
Long-Term Debt	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	2.91	0.00
Total Non-Current Liabilities	0.72	0.00	0.00	0.00	0.00	2.91	0.00
Total Liabilities	2.72	1.91	5.56	4.45	2.14	6.34	0.03
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	73.51	0.00
Retained Earnings	-49.42	-40.51	-25.47	-25.35	-14.52	-5.69	0.00
Additional Paid-in Capital	58.28	45.21	32.11	26.40	14.42	5.54	0.00
Shares Outstanding	1.58	0.04	0.00	0.00	0.00	-	-
Total Stockholders' Equity	8.86	4.71	6.65	1.05	-0.10	67.82	0.00
Total Liabilities & Equity	11.58	6.62	12.21	5.50	2.04	4.62	0.02

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Revelation Biosciences Balance Sheet

How much debt does Revelation Biosciences have?

Revelation Biosciences had total debt of $746.78K as of Dec 31, 2025, against $10.70M in cash and short-term investments. Its debt-to-equity ratio was 0.08. Total debt was $0.00 a year earlier.

What are Revelation Biosciences's total assets?

Revelation Biosciences reported total assets of $11.58M as of Dec 31, 2025, up 74.9% from $6.62M a year earlier. Total liabilities were $2.72M.

What is Revelation Biosciences's shareholders' equity?

Revelation Biosciences's shareholders' equity was $8.86M as of Dec 31, 2025, or about $5.59 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition